REMOGLIFLOZIN belongs to the class of antidiabetic drugs, primarily used to treat type 2 diabetes mellitus and non-alcoholic steatohepatitis (non-alcoholic fatty liver disease). Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas produces little or no insulin at all. REMOGLIFLOZIN is not indicated for use in type 1 diabetes.
REMOGLIFLOZIN contains Remogliflozin. It is a sodium-glucose transporter 2 inhibitor and works by reducing blood sugar levels by eliminating excess sugars from the body through urine. Thus, it helps improve glycaemic control (control of glucose levels) in diabetic patients. REMOGLIFLOZIN also lowers the risk of heart failure in type 2 diabetic patients with heart diseases.
Take REMOGLIFLOZIN as advised by your doctor. Some common side effects of REMOGLIFLOZIN include nausea, frequent urge to urinate, low blood sugar levels, fungal infection in the genital area, and increased thirst. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
REMOGLIFLOZIN may cause hypoglycaemia (low blood sugar); hence it is advised to take healthy food with enough calories and avoid heavy exercise. Do not take or stop this medicine if the doctor did not advise you to do so. Before starting REMOGLIFLOZIN, let your doctor know if you have any medical history of heart, kidney or liver diseases, breathing problems, blood disorders, dehydration, alcohol use, low blood pressure, and yeast infection of genitals. It is advised to avoid alcohol intake while using REMOGLIFLOZIN. REMOGLIFLOZIN should be used only when prescribed by a doctor if you are pregnant or breastfeeding.
Type 2 Diabetes mellitus.
REMOGLIFLOZIN treats type 2 diabetes mellitus and contains Remogliflozin. It works by reducing blood sugar levels by eliminating excess sugars from the body through urine. REMOGLIFLOZIN also reduces the risk of heart failure in patients with type 2 diabetes and heart disease. REMOGLIFLOZIN may be advised with or without other medications along with diet and exercise to control blood sugar levels.
Inform your doctor if you take other antidiabetic drugs so that your doctor may adjust the dosage of REMOGLIFLOZIN accordingly. Do not abruptly stop taking REMOGLIFLOZIN midway if the doctor did not advise you. REMOGLIFLOZIN may cause hypoglycaemia (low blood sugar); hence it is advised to take healthy food with enough calories and avoid heavy exercise. Brief your medical history to doctor if you have any heart, kidney or liver diseases, breathing problems (asthma, obstructive lung diseases), blood problems like anaemia (lack of blood cells), vitamin B12 deficiency, pancreas problems/surgery, dehydration, alcohol use, low blood pressure, and yeast infection of genitals before taking REMOGLIFLOZIN. REMOGLIFLOZIN should be used only when prescribed by a doctor if you are pregnant or breastfeeding. Your doctor may advise alternate medications to control your diabetic condition in such cases.
Drug-Drug Interaction: REMOGLIFLOZIN may interact with antibiotics (Fluconazole), drugs treating impotence (Sildenafil), antidiabetics (Glimepiride), and anticonvulsants (Pregabalin).
Drug-Food Interaction: Avoid alcohol intake since it may increase the risk of low blood sugar levels.
Drug-Disease Interaction: Tell your doctor before taking REMOGLIFLOZIN if you have any heart, kidney or liver diseases, breathing problems, blood disorders, dehydration, alcohol use, low blood pressure, and yeast infection of genitals.
It is advised to avoid alcohol intake since it may worsen the risk of developing low blood sugar levels.
Gliflozins are usually not recommended during the second or third trimester of pregnancy. Your doctor may suggest other medications to control your blood sugar levels. Please consult your doctor before starting REMOGLIFLOZIN if you are pregnant or planning to conceive.
There is limited information on how REMOGLIFLOZIN affects breastfeeding. Please seek medical advice for further information.
Your driving ability may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you experience blurred vision, dizziness or drowsiness due to extremely low or high blood sugar.
Let your doctor know if you have any history of liver diseases or hepatic impairment. Your doctor will prescribe REMOGLIFLOZIN only if the benefit outweighs the risk.
Let your doctor know if you have any history of kidney diseases. Your doctor will prescribe REMOGLIFLOZIN only if the benefit outweighs the risk.
Your child’s doctor will decide whether to give REMOGLIFLOZIN to children or not
Diabetes mellitus: It is also known as adult-onset diabetes, a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance) or the pancreas (an organ behind the stomach) produce little or no insulin at all. This disease mainly occurs in people aged above 40 years but can also occur in childhood based on the risk factors. The treatment includes oral glucose-lowering medicines and insulin shots.